According to Article 11 of the Therapeutic Products Ordinance of 21 September 2018 (SR 812.212.21), the applicant must notify Swissmedic of the non-marketing, interruption of distribution or discontinuation of distribution for a medicinal product within the specified time limits. These notifications to Swissmedic were previously made using the same form for both human and veterinary medicinal products.
A separate form No marketing / interruption of distribution VMP has now been created for notifications concerning veterinary medicinal products (VMP).
The existing form No marketing / interruption of distribution will in future be used exclusively for human medicinal products (HMP) and will be revised accordingly.
The current guidance document No marketing / interruption of distribution and the related directory Overview of documents to be submitted continue to apply to both HMP and VMP and have been revised accordingly.
The new form No marketing / interruption of distribution VMP and the revised specification documents are valid as of 1 September 2024.